Finding early markers for liver cancer in people with chronic liver disease
Part of Digestive system, Infections clinical trials.
This study looks for substances in your blood and immune system that could help doctors find liver cancer earlier. It is for people with liver cancer caused by chronic liver problems like hepatitis C, cirrhosis, or scarring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a long-term liver condition (like chronic infection, scarring, cirrhosis, or hepatitis C) that led to liver cancer
- You are willing to sign a consent form and answer a questionnaire
- You are not being treated for another cancer
- You do not have a weakened immune system from HIV, an organ transplant, or from medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This study looks at how well doctors can detect small, early liver cancer and then follow how it changes over time. It may help your care team choose the best next steps based on earlier, clearer detection.
This study tests a digital (computer/phone-based) system to help track people with higher risk of liver cancer so cancers can be found earlier. It may help by guiding regular check-ins and making early diagnosis more efficient.
This study aims to predict the risk of developing liver cancer in people with chronic liver conditions such as hepatitis B or C, cirrhosis, or fatty liver disease. By participating, you may help researchers improve early detection and prevention strategies for liver cancer.
This study tests a new way to find liver cancer early in people who are at higher risk, using regular ultrasound and blood tests. If you qualify, you'll get close monitoring to catch any problems sooner, which may improve treatment options.
This study is looking for people with or without liver cancer to test a new way to find liver cancer early using blood or tissue samples. It aims to help catch the disease sooner.
Hear when a new Hepatitis C Virus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.